Search Within

David G Pfister

  1. "Medical Physics"
Formats
  1. Journal Article (19)
  2. Meeting Abstract (16)
Groups
  1. Department of Medicine (35)
  2. Head and Neck Service (35)
  3. Medical Physics (35)
  4. Solid Tumor Oncology Division (35)
  5. Radiation Oncology, Department of (33)
  6. Survivorship Research (25)

More Groups

People
  1. Nancy Lee (27)
  2. Dennis Kraus (16)
  3. Suzanne Wolden (16)
  4. Amita Dave (11)
  5. Eric Sherman (10)
  6. James Mechalakos (10)

More People

Years
  1. 2024 (1)
  2. 2023 (1)
  3. 2022 (1)
  4. 2021 (1)
  5. 2020 (2)
  6. 2017 (2)

More Years

Publications
  1. International Journal of Radiation Oncology, Biology, Physics (23)
  2. Journal of Clinical Oncology (7)
  3. Cancer (1)
  4. JAMA Network Open (1)
  5. JNCI: Journal of the National Cancer Institute (1)
  6. Lancet Oncology (1)

More Publications

Publishers
  1. Elsevier Inc. (23)
  2. American Society of Clinical Oncology (7)
  3. American Medical Association (1)
  4. Elsevier Science, Inc. (1)
  5. Massachusetts Medical Society (1)
  6. Oxford University Press (1)

More Publishers

Results (35)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Hypoxia-directed treatment of human papillomavirus-related oropharyngeal carcinoma
    Journal Article

    Lee, N. Y.; Sherman, E. J.; Schòˆder, H.; Wray, R.; Boyle, J. O.; Singh, B.; Grkovski, M.; Paudyal, R.; Cunningham, L.; Zhang, Z.; more...
    Journal of Clinical Oncology (2024)

    Fulltext@MSK | Save
  • Long-term outcomes of bevacizumab and chemoradiation for locoregionally advanced nasopharyngeal carcinoma: A nonrandomized controlled trial
    Journal Article

    Lee, N. Y.; Harris, J.; Kim, J.; Garden, A.; Mechalakos, J.; Pfister, D. G.; Chan, A. T. C.; Hu, K.; Colevas, A. D.; Frank, S.; more...
    JAMA Network Open (2023)

    Fulltext@MSK | Save
  • Phase 2 of trametinib plus radioiodine in RAS-mutant and wild-type, radioiodine-refractory thyroid cancer (ETCTN9446)
    Meeting Abstract

    Burman, B.; Tuttle, R. M.; Grewal, R. K.; Sherman, E. J.; Baxi, S. S.; Boucai, L.; Sabra, M.; Fish, S.; Pentlow, K. S.; Haque, S.; more...
    Journal of Clinical Oncology (2022)

    Fulltext@MSK | Save
  • Precision radiotherapy: Reduction in radiation for oropharyngeal cancer in the 30 ROC trial
    Journal Article

    Riaz, N.; Sherman, E.; Pei, X.; Schòˆder, H.; Grkovski, M.; Paudyal, R.; Katabi, N.; Selenica, P.; Yamaguchi, T. N.; Ma, D.; more...
    JNCI: Journal of the National Cancer Institute (2021)

    Fulltext@MSK | Save
  • Long-term update of a phase II study of concurrent chemoradiotherapy using radiation + bevacizumab (BV) for locally or regionally advanced nasopharyngeal cancer (NPC): RTOG 0615
    Meeting Abstract

    Lee, N.; Harris, J.; Pfister, D. G.; Kim, J.; Garden, A. S.; Mechalakos, J. G.; Chan, A. T. C.; Hu, K. S.; Yom, S. S.; Glisson, B. S.; more...
    International Journal of Radiation Oncology, Biology, Physics (2020)

    Fulltext@MSK | Save
  • Genetic and micro-environmental factors influencing response to definitive 30Gy chemo-radiotherapy (chemoRT) in HPV positive oropharyngeal cancer (OPC)
    Meeting Abstract

    Riaz, N.; Sherman, E.; Pei, X.; Schoder, H.; Paudyal, R.; Katabi, N.; Ma, D. J.; Tsai, C. J.; McBride, S.; Morris, L. G.; more...
    International Journal of Radiation Oncology, Biology, Physics (2020)

    Fulltext@MSK | Save
  • A personalized approach using hypoxia resolution to guide curative-intent radiation dose-reduction to 30 Gy: A novel de-escalation paradigm for HPV-associated oropharynx cancers (OPC)
    Meeting Abstract

    Riaz, N.; Sherman, E. J.; Katabi, N.; Leeman, J. E.; Higginson, D. S.; Boyle, J.; Singh, B.; Morris, L. G.; Wong, R. J.; Tsai, C. J.; more...
    Journal of Clinical Oncology (2017)

    Fulltext@MSK | Save
  • A personalized approach using hypoxia resolution to guide curative-intent radiation therapy dose-reduction to 30 Gy: A novel de-escalation paradigm for HPV-associated oropharynx cancers treated with concurrent chemoradiation therapy
    Meeting Abstract

    Riaz, N.; Sherman, E.; Katabi, N.; Leeman, J. E.; Higginson, D. S.; Boyle, J. O.; Singh, B.; Morris, L.; Wong, R. J.; Tsai, C. J.; more...
    International Journal of Radiation Oncology, Biology, Physics (2017)

    Fulltext@MSK | Save
  • Strategy of using intratreatment hypoxia imaging to selectively and safely guide radiation dose de-escalation concurrent with chemotherapy for locoregionally advanced human papillomavirus-related oropharyngeal carcinoma
    Journal Article

    Lee, N.; Schoder, H.; Beattie, B.; Lanning, R.; Riaz, N.; McBride, S.; Katabi, N.; Li, D.; Yarusi, B.; Chan, S.; more...
    International Journal of Radiation Oncology, Biology, Physics (2016)

    Fulltext@MSK | Save
  • Selumetinib-enhanced radioiodine uptake in advanced thyroid cancer
    Journal Article

    Ho, A. L.; Grewal, R. K.; Leboeuf, R.; Sherman, E. J.; Pfister, D. G.; Deandreis, D.; Pentlow, K. S.; Zanzonico, P. B.; Haque, S.; Gavane, S.; more...
    New England Journal of Medicine (2013)

    Fulltext@MSK | Save